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cells for nucleic acid amplification, hybridization 
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Abstract 
Background: Formalin has been widely used by pathology laboratories. Its carcinogenicity has led researchers to 
explore formalin substitutes. Streck Cell Preservative (SCP) is a formalin-free preservative that can preserve cellular 
antigens. This study was undertaken to investigate the effects of cell preservation using SCP on nucleic acid amplifica-
tion, hybridization, and next-generation sequencing (NGS) as compared to control frozen cells and cells fixed in the 
traditional cell and tissue fixative, 10 % neutral buffered formalin (NBF).
Findings: The breast cancer cell line, SKBR-3, was used as a model system. Prior to nucleic acid extraction and 
fluorescence in situ hybridization (FISH), cells were fixed in SCP or NBF overnight at room temperature with frozen 
cells in parallel. Analysis showed that similar DNA extraction yields and amplification profiles determined by PCR in 
SCP preserved cells and control frozen cells, whereas NBF preserved cells had decreased DNA yield and impaired PCR 
amplification. Molecular cytogenetic studies by FISH technique indicated that the ratios of ERBB2 (HER-2/neu) signals 
to the chromosome 17 centromere (CEP17) were comparable for frozen cells and SCP preserved cells. The fluores-
cence images of both SCP fixed and control frozen cells were also clear and comparable. On the contrary, the same 
analysis was unsuccessful with NBF preserved cells due to poor hybridization quality. Our data also demonstrated that 
SCP had negligible effect on NGS testing.
Conclusion: We conclude that SCP can be used as an alternative to NBF as a preservative for maintaining the integ-
rity of nucleic acids for nucleic acid amplification, sequencing and FISH analysis.
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Background
Preservation of cell and tissue morphology and antigenic-
ity in clinical specimens is the foundation step in accurate 
diagnoses. Formalin has been a traditional and popular 
choice of preservative for this purpose [1]. Formalin pre-
served cells and tissues exhibit excellent morphology and 
acceptable antigenicity, but there are some major draw-
backs. Studies show that formalin exerts a carcinogenic 
effect and poses health risks to the laboratory users [2]. 
Formalin causes detrimental effects on biomolecules, 
mainly by crosslinking reactions [3, 4]. The later effect 
is particularly relevant in nucleic acid based molecular 
diagnosis, as nucleic acids are often fragmented, chemi-
cally modified and difficult to extract from a formalin 
preserved pathological specimen [4–6]. During the last 
two decades, many attempts have been made to optimize 
existing processing procedures or introduce alternative 
fixatives to formalin, but formalin is still widely used as 
the preferred cell and tissue preservative in pathology 
laboratories [7–9].
Streck cell preservative (SCP) is a formalin-free pre-
servative [10]. Previous studies demonstrate that SCP 
preserves cellular antigens for immunophenotyping 
by flow cytometry [11]. In this study, we compared 
nucleic acid integrity in samples preserved using SCP 
and formalin. We utilized droplet digital PCR (ddPCR) 
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based technique to study nucleic acid amplifiability and 
fluorescence in  situ hybridization (FISH) analysis for 
cytogenetic integrity. Compatibility of SCP with next-
generation sequencing (NGS) technique was evaluated as 
well, as these methods are in the frontier of present day 




Formaldehyde (Cat. No. BDH0500-1LP) was purchased 
from BDH (Epping, NSW, Australia) and NaH2PO4 & 
Na2HPO4 from Sigma-Aldrich (St. Louis, MO). Streck 
Cell Preservative™ (SCP) was obtained from Streck Inc., 
Omaha, NE, USA. Colcemid® solution (Cat. No. 9311) 
was purchased from Irvine Scientific (Irvine, CA, USA). 
Glacial acetic acid (Cat. No. 2504-14) was purchased 
from Mallinckrodt Chemical Inc. (St. Louis, MO, USA). 
Anhydrous methanol (Cat. No. AC61009-0040) was pur-
chased from Acros Organics (Geel, Belgium).
Cell preservation for DNA experiments
The breast cancer cell line, SKBR-3, was obtained from 
American Type Culture Collection (Rockville, MD, USA) 
and routinely passaged in ATCC formulated modified 
McCoy’s 5a medium (Cat. No. 30-2007) containing 10 % 
fetal bovine serum at 37 °C in humidified atmosphere of 
5 % CO2.
SKBR-3 cells grown to 70–80 % confluence were tripsi-
nized and washed two times with phosphate buffer solu-
tion (PBS) and suspended in fresh PBS. The cells were 
equally divided into three sets and transferred into three 
eppendorf tubes containing 1  ×  106 SKBR-3 cells. One 
set of cells was snap frozen at −80 °C to be used as a con-
trol. The cells in the second tube were suspended in 1 mL 
SCP diluted with PBS in 1:1 volume ratio. The third set 
of cells was suspended in 1 mL of 10 % neutral buffered 
formalin (NBF). 10 % NBF was prepared according to the 
standard protocol (100  mL of formaldehyde, 900  mL of 
distilled water, 4.0 g of NaH2PO4, 6.5 g of Na2HPO4, mix 
to dissolve.). Both tubes were incubated at room temper-
ature overnight (15–18 h). At the end of the incubation 
period, the cells were washed twice with PBS and cell pel-
lets were used to extract DNA.
DNA extraction
DNA was extracted from control cells (snap frozen) as 
well as cells fixed with 10 % NBF and SCP using QIAamp 
DNA FFPE Tissue kit (Qiagen, Santa Clarita, CA). The 
manufacturer’s recommended protocol was followed 
with slight modification. Steps 1–9 of the protocol were 
omitted. DNA extraction began at step 10 by treating the 
cell pellet (1 × 106 cells) with buffer ATL and proteinase 
K. Steps 11–21 in the manufacturer’s recommended pro-
tocol were followed. Finally, DNA was eluted in 60 µL 
of elution buffer (Buffer ATE). DNA concentration was 
determined using Qubit® 2.0 fluorometer and Qubit® 
dsDNA HS assay kit (Invitrogen, Eugene, Oregon, USA). 
DNA was stored at −80  °C until analysis by ddPCR or 
NGS.
DNA analysis by ddPCR
β-actin copy number assay: Additional file  1: Table S1 
provides sequence information for primers and probes 
for the ddPCR assay to amplify long, medium and short 
amplicons from the β-actin gene. All primers were pur-
chased from Integrated DNA Technologies (IDT) (Cor-
alville, IA). A PCR master mix, 2X ddPCR™ Supermix for 
Probes, was purchased from Bio-Rad Laboratories (Her-
cules, CA). Final concentrations of primers and probe 
in PCR reactions were 900  nM and 250  nM, respec-
tively, in a final volume of 20 μL. Equal amount of DNA 
(5 ng) from each sample was used for PCR reactions. A 
Bio-Rad QX100 Droplet Digital™ PCR System was used 
as described by Hindson and colleagues [12]. Thermal 
cycling was performed with a Bio-Rad C1000 Touch 
Thermal Cycler. The following PCR conditions were used: 
10 min at 98 °C, 40 cycles of 30 s at 95 °C, 30 s at 54 °C, 
and 30 s at 72 °C. A final extension was done for 10 min 
at 72 °C followed by a heating step for 10 min at 98 °C to 
inactivate the polymerase. Data analysis was performed 
using Bio-Rad QuantaSoft software version 1.3.2.
HER-2/CEP17 ratio assay: ERBB2 (HER-2/neu) status 
is defined as the ratio between ERBB2 (HER-2/neu) copy 
number and chromosome 17 centromere copy number 
(CEP17). For the detection of HER-2 DNA copy number, 
ERBB2 assay (HER-2: Hs02803918_cn, Applied Biosys-
tems) was used. As previously described [15], primers 
and probe for CEP17 assay were synthesized and assays 
were carried out using the ddPCR system.
DNA analysis by NGS
Genomic DNA libraries were prepared from snap frozen 
and SCP derived DNA using Illumina® TruSight Rapid 
Capture kit (Cat. No. FC-140-1101). According to the 
manufacturer’s protocol, 10  μL of DNA at 5  ng/10 μL 
(n = 3) was used in the tagmentation reaction, followed 
by limited-cycle PCR amplification. After clean up, the 
DNA libraries were pooled and hybridized with cap-
ture probes using Illumina TruSight Cancer sequencing 
panel (Cat. No. FC-121-0202). To ensure high specificity 
of the captured regions, a second hybridization and cap-
ture process was performed. The captured libraries were 
finally amplified via another limited-cycle PCR program 
and sequenced on an Illumina HiSeq 2500 sequence ana-
lyzer. The reads were pre-processed using fqtrim (http://
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ccb.jhu.edu/software/fqtrim/index.shtml) to remove any 
N that was present. The resulting reads were sequentially 
aligned to hg19 human genome (UCSC version, February 
2009) using the Burrows-Wheeler alignment tool.
ERBB2 (HER‑2/neu) FISH assay
SKBR-3 cells were grown in three T-25 flasks to approxi-
mately 75 % confluence. A 50 µL solution (10 µg/mL) of Col-
cemid was added to each flask and incubated for 20 min at 
37 °C. Cells were removed from each flask by trypsinization, 
transferred to a 15 mL tube and pelleted by centrifuging at 
1000 rpm for 8 min. The cell pellets were re-suspended in 
6 mL of hypotonic solution (0.075 M KCl warmed to 37 °C) 
and incubated for 20 min at 37 °C. For the control sample, 
1 mL of 3:1 methanol:glacial acetic acid fixative was added 
to the cells and incubated at room temperature for 5 min 
before centrifugation at 1200  rpm for 6  min to remove 
hypotonic/fixative supernatant. Cells were washed three 
times with 6  mL of  the same fixative and finally re-sus-
pended in 1.5 mL of the fixative for storage at 4 °C. For the 
SCP and NBF test samples, cells were first incubated with 
hypotonic solution, washed with PBS and then suspended 
either in 1 mL of SCP:PBS (1:1) or in 10 % NBF. After incu-
bation at room temperature for 18 h, preserved cells were 
washed and re-suspended in PBS for storage at 4 °C.
Slides were prepared for fluorescence in situ hybridiza-
tion (FISH) at 25  °C and 40 % relative humidity using a 
cytogenetic drying chamber (Thermatron, Holland, MI) 
and were aged at 100 °C for 2 min. Interphase FISH stud-
ies were performed using the PathVysion HER-2 DNA 
Probe Kit (Abbott Molecular, Des Plaines, IL) specific for 
the ERBB2 (HER-2/neu) locus at 17q11.2-q12 and the 17 
centromere (D17Z1). The cells and probes were co-dena-
turated at 78  °C for 3 min using the ThermoBrite™ sys-
tem (Abbott Molecular) and incubated overnight at 37 °C 
in a humidified chamber.
Nuclei were counterstained with 4, 6-diamidino-2-phe-
nylindole (DAPI) in Antifade solution (Abbott Molecu-
lar), and the slides were analyzed using a Leica DM6000B 
fluorescence microscope (Leica Biosystems, Inc., Buffalo 
Grove, IL). Hybridization signals for ERBB2 (HER-2/neu) 
and the 17 centromere were assessed in 30 interphase 
nuclei per specimen, and the observed signal patterns 
were interpreted utilizing the 2013 ASCO/CAP ERBB2 
(HER-2/neu) reporting guidelines [14]. Images were 
acquired and archived using the CytoVision Image Analy-
sis System (Leica Biosystems, Inc.).
Statistical analysis
Statistical analysis was carried out using Microsoft Excel 
for Office 2007. Analysis was performed using paired, 
two-tailed Student’s t test and p  <  0.05 was considered 
statistically significant.
Findings
Effect of fixatives on DNA yield and PCR amplification
Cultured SKBR-3 cells were re-suspended in SCP (1:1 
diluted with PBS) or 10  % NBF and stored overnight at 
room temperature with unfixed frozen cells in parallel. 
Genomic DNA was purified from these three different 
groups of cells and quantified by the fluorescence-based 
Qubit® assay. The mean DNA yield from unfixed control 
(frozen) cells was 2.4 ± 0.7 µg/106 cells. Similar amounts 
of DNA were obtained from SCP preserved cells with a 
mean concentration of 2.2  ±  0.7  µg/106 cells, showing 
no statistically significant difference from control cells 
(p = 0.116, n = 10). Conversely, fixation of cells by 10 % 
NBF resulted in a significantly lower (p = 0.0001) DNA 
yield than the control or SCP samples. The mean DNA 
yield of NBF fixed cells was 0.14 ± 0.2 µg/106 cells.
Potential DNA fragmentation and damage caused by 
fixation was assessed using two different PCR amplifi-
cation assays. The first assay was designed to amplify a 
series of fragment lengths from the same target gene, 
β-actin. The sizes of three nested amplicons are 69 base 
pairs (bp), 152 and 420 bp, respectively. As shown in the 
Fig.  1a, the average copy numbers of the 69  bp β-actin 
amplicon for the control, SCP and NBF treated cells 
were 996, 756 and 896 copies per ng DNA, respectively 
(n  =  10). In contrast, for the amplification of 152  bp 
amplicon (Fig.  1b), the mean copy numbers were 955, 
836 and 188 copies per ng DNA for control, SCP and 
NBF treated samples, respectively. A similar pattern of 
the amplifiable input DNA was observed in the 420  bp 
fragment test (Fig.  1c) as the 152  bp amplification. The 
detected copy number was decreased dramatically from 
459 copies per ng DNA of control cells or 314 copies per 
ng DNA of treated cells to 25 copies per ng DNA of NBF 
fixed cells. For all these tests, there was no statistically 
significant difference in the amount of amplifiable DNA 
between frozen control and SCP treated cells. However, 
cells treated with NBF showed statistically significant 
decrease in target copy numbers of 152  bp and 420  bp 
compared to the control cells.
In another ddPCR assay, HER-2 genomic DNA copy 
number alterations were measured and normalized to the 
CEP17 reference gene. Table 1 shows HER-2 and CEP17 
genomic DNA copy numbers and HER-2 to CEP17 
ratios (n = 10). NBF fixation impaired PCR amplification 
resulting in significant reduction in HER-2 and CEP17 
copy numbers. As compared to the control samples, 
cells treated with NBF showed 63.0-fold and 397.6-fold 
decreases in HER-2 and CEP17 copy numbers, respec-
tively. This dramatic decrease in CEP17 copy number 
contributed to the abnormally high HER-2/CEP17 ratio 
(44.3) in NBF treated cells. In contrast, SCP treatment 
slightly affected amplifiable DNA available for the PCR 
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assay. There was about 1.4-fold decrease in both HER-2 
and CEP17 copy numbers. The HER-2/CEP17 ratios were 
similar for the control (7.0) and SCP treated (6.9) cells 
(Table 1).
Effect of fixatives on DNA hybridization
FISH studies were performed for assessment of the 
ERBB2 (HER-2/neu) locus and the chromosome 17 cen-
tromere for controls cells and those cells treated with 
SCP or NBF. As shown in Fig. 2, hybridization of HER-2 
and the chromosome 17 centromere was unsuccessful for 
the cells exposed to NBF in all experiments (n = 5). Con-
versely, no hybridization failure was observed in any of 
the control or SCP cell preparations performed simulta-
neously. Qualitatively, the cells exposed to SCP exhibited 
crisper, more precise chromosome 17 centromere sig-
nals as compared to the control cells. The HER-2 signals 
in the SCP exposed cells were slightly dimmer than the 
HER-2 signals when compared to the control cells; how-
ever, the signal intensity was not prohibitive for assess-
ment or enumeration of the HER-2 locus in either the 
SCP exposed or control cells.
The mean copy number of HER-2 and chromosome 17 
centromere signals in the SCP cells was 52.84 and 6.40, 
respectively; there was no statistically significant differ-
ence from control cells for either of these loci (p = 0.23 
and p = 0.27, respectively). The mean ratio of HER-2 to 
the chromosome 17 centromere for SCP cells was 8.27 
and was also not statistically significant from the mean 
ratio of HER-2 to 17 centromere in the control cells 
(p = 0.39). Given the lack of successful hybridization for 
the HER-2 and 17 centromere loci in the NBF preserved 
cells, comparison with this population was not possible.
NGS application of DNA from SCP treated samples
To explore if SCP-derived DNA is compatible with 
NGS technology, we did an Illumina-based sequenc-
ing study. As described in “Materials and Methods” 
section, sequencing libraries of DNA extracted from 
snap frozen or SCP-treated SKBR-3 cells were prepared 
using Illumina TruSight Rapid Capture kit and capture 
enriched by TruSight Cancer Sequencing Panel. An Illu-
mina HiSeq  2500 sequence analyzer was utilized as the 
NGS platform in this study. We first compared common 
NGS quality parameters across the two types of samples, 
i.e., snap frozen and SCP treated (Table  2). There was 
no statistically significant difference in mapping results 
obtained from two sample types. The percentage of bases 
that were mapped was 51.3 and 50.8  % for frozen and 
SCP samples, respectively. The estimation of error rates 
indicated by discrepancies also showed no significant dif-
ference between the two sample types. Similar numbers 
of base with Phred mapping score of 20 or less per reads 











































































Fig. 1 DNA integrity assayed by β-actin ddPCR. DNA templates were extracted from snap frozen SKBR-3 cells and cells treated with 10 % NBF or 
SCP. Three different fragment lengths from the same target gene β-actin were amplified. The sizes of three nested amplicons are 69 bp (a), 152 bp 
(b) and 420 bp (c), respectively. Mean copy numbers are shown with error bars indicating standard deviation, n = 10. *P < 0.005
Table 1 HER-2/CEP17 ratio in control and fixed SKBR-3 cells as determined by ddPCR (mean ± SD)
Sample Type HER‑2 CEP17 HER‑2/CEP17
Copies/106 cells Copies/106 cells Ratio
Frozen control cells 10,288,417 ± 4,535,976 1,465,957 ± 763,934 7.0 ± 1.1
10 % NBF fixed cells 163,256 ± 147,676 3,687 ± 3,815 44.3 ± 12.8
SCP fixed cells 7,380,677 ± 4,069,048 1,063,169 ± 678,786 6.9 ± 1.4
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We further examined if the SCP treatment affected 
sequencing of target regions of interest. The TruSight 
Cancer Sequencing Panel utilized in this study covers 94 
target genes. As summarized in Additional file 2: Table 
S2, there were only minor differences in average depth of 
coverage by gene between frozen and SCP samples and 
none of these differences were statistically significant.
Discussion
Significant advancement has been made in recent years 
in molecular testing technologies. As such, molecular 
diagnostic tests are being developed to complement tra-
ditional histological and immunohistological diagnostic 
tests in disease diagnosis [16]. Although formalin has 
been widely used by pathology laboratories to preserve 
histomorphologic features of specimens, its carcino-
genicity and adversity towards molecular integrity have 
prompted researchers to explore formalin substitutes. 
SCP is a non-formalin fixative designed to preserve cel-
lular antigens. However, applications of SCP to samples 
used in molecular testing were yet to be assessed. This 
study was designed to investigate effects of this fixative 
on cellular nucleic acid extraction yield and integrity as 
compared to 10  % NBF and snap frozen samples using 
the SKBR-3 cell line as a model.
Formalin can interact with macromolecules in mul-
tiple ways. For example, formalin fixation induces not 
only protein–protein, but also DNA–protein cross-link-
ing [4, 16]. The protein networks resulting from protein–
protein cross-linking may cause DNA trapping, whereas 
DNA–protein cross-linking reduces DNA solubility. 
These effects make it difficult to extract DNA from NBF 
fixed samples. In addition, formalin can also cause DNA 
degradation via hydrolysis of phosphodiester bonds [4]. 
The combination of these factors may explain why the 
DNA yield recovered from NBF treated cells was sig-
nificantly lower than the yield from snap frozen con-
trol cells. Similarly, Serth et  al. reported that formalin 
fixation strongly impaired DNA yield [17]. Heating can 
reverse some of cross-linking effects of formalin [18]. 
Both Serth’s and our DNA isolation protocols contained 
heating steps, but cross-linking caused by formalin can 
still be problematic after heating if extensive cross-link-
ing occurs. Moreover, spectrophotometry is not suitable 
for quantification of DNA derived from a fixed sample 
[19]. Thus, we used a fluorescence-based method to 
measure double stranded DNA concentration. Another 
advantage using this method was to avoid interference of 
RNA contaminated in DNA samples. However, chemi-
cal modification to DNA functional groups can inhibit 
DNA double helix formation, resulting in decreased flu-
orescence intensity and low DNA quantity [20]. Interest-
ingly, non-formalin SCP fixed samples yielded a similar 
amount of DNA as snap frozen samples. This indicates 
Fig. 2 DNA hybridization assayed by ERBB2 (HER-2/neu) FISH. SKBR-3 cells were snap frozen (a) or exposed to 10 % NBF (b) or SCP (c) prior to FISH 
analysis. Representative cell nuclei are shown for HER-2 amplification (green) and multiple copies of CEP17 (red), as well as countstain with DAPI 
(blue). n = 5
Table 2 Comparison of  average sequencing quality met-
rics
a On-target means mapping to the targets
b Discrepancies mean any base called in a read that is different from the
reference sequence
c Q20: Phred mapping quality score of 20
Frozen control SCP p value
Total reads (×106) 24.6 ± 0.33 34.1 ± 1.86 0.01
Unique reads (×106) 2.89 ± 1.26 4.75 ± 0.63 0.23
Mapped unique reads (×106) 2.45 ± 1.11 4.15 ± 0.60 0.22
Bases on-targeta (×106) 89.8 ± 47.4 177 ± 32.16 0.19
% Bases on-target 51.3 ± 0.02 50.8 ± 0.00 0.69
Total discrepanciesb (×105) 1.17 ± 0.31 1.75 ± 0.27 0.14
Discrepancies per read 0.06 ± 0.04 0.04 ± 0.00 0.55
Number of bases <Q20c (×106) 0.77 ± 0.29 1.23 ± 0.26 0.20
Number of bases <Q20 per reads 0.46 ± 0.20 0.60 ± 0.61 0.63
Mean insert size 98 ± 5.51 119 ± 5.20 0.07
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a chemically unaltered DNA structure in SCP preserved 
cells.
PCR is a powerful tool to measure the fraction of DNA 
that can be amplified, an indicator of DNA quality/integ-
rity and the size distribution of fragmented DNA. In the 
present study, nested fragments of three different lengths 
from the same target DNA were amplified in the β-actin 
ddPCR assay. On the one hand, the target copy num-
bers of NBF samples were significantly lower than those 
in control or SCP samples in both the large amplicon 
size test of 420 bp and the medium amplicon size test of 
152 bp, but not in the short ampilcon test of 69 bp. This 
was largely due to the DNA fragmentation effect caused 
by NBF fixation. The fragmentation significantly reduced 
the amplifiable DNA input for relatively long PCR ampli-
fication tests. On the other hand, PCR efficiency can 
be affected by amplicon size. Large amplicons leads to 
decreased PCR efficiency. Target copy numbers moder-
ately decreased from 996 of 69 or 955 of 152 to 459 of 
420  bp for the snap frozen control samples. The SCP 
samples showed a similar pattern as control cells. How-
ever, a dramatic decrease in target copy numbers was 
observed in NBF samples. For example, the copy number 
was reduced 36 fold from 896 of 69 to 25 of 420 bp for 
NBF samples. The changes in the frozen control and SCP 
samples were only 2.2 and 2.4 fold, respectively. Taken 
together, these moderate fold changes found in the con-
trol or SCP samples were likely due to the PCR efficiency 
effect, whereas the much larger fold change observed in 
the NBF samples was a result of the combined effects of 
fragmentation and PCR efficiency, with the former as the 
main driving effect. This suggests remarkable fragmen-
tation of DNA in NBF fixed samples, but not in SCP or 
snap frozen control samples.
HER-2 is a member of the human epidermal growth 
factor receptor family. Amplication or overexpression 
of HER-2 is involved in development and progression of 
certain types of cancer, particularly breast cancer. Thus, 
determination of HER-2 status is extremely useful in the 
assessment of breast cancer for treatment purposes [13]. 
The SKBR-3 model used in the present study is a breast 
cancer cell line with known alterations in HER-2 and 
CEP17. We examined the effect of fixatives on HER-2 
copy number measurements by ddPCR. Similar to the 
β-actin ddPCR result, SCP treatment only caused mini-
mal decreases in both HER-2 and CEP17 copy numbers 
compared to the control sample. The HER-2/CEP17 
ratios of control and SCP samples were similar to each 
other, suggesting SCP’s effect on HER-2/CEP17 test-
ing was negligible. However, NBF fixation resulted in a 
very low HER-2 copy number. Moreover, CEP17 copy 
number was even further diminished. One possibility is 
that CEP17 DNA region is more prone to fragmentation 
from NBF fixation. Because of the remarkable decrease 
in CEP17 copy number, the HER-2/CEP17 ratio was 
6.3 times higher in NBF than in control or SCP sam-
ples. FISH is another way to assess HER-2 amplification, 
which is routinely performed in current clinical settings. 
Our FISH data matched PCR data in regard to the effect 
of fixatives on HER-2 amplification testing. In particular, 
the mean HER-2/CEP17 ratio of SCP cells from FISH 
was 8.27. This is comparable to the ratios of 7.0 and 6.9 
obtained from the PCR assay for control and SCP cells, 
respectively. Our data is also confirmed by Pat et  al. 
who reported a HER-2/CEP17 ratio of 7.25 in SKBR-3 
cells using FISH analysis [21]. The hybridization failure 
observed in NBF cells may be due to poor probe penetra-
tion through fixed cell membrane, DNA fragmentation 
or both.
NGS has emerged as another powerful molecular tech-
nique. We observed some rare discrepancies between 
snap frozen and SCP cells. The total number of reads 
generated from frozen samples was lower than that from 
SCP samples. This is likely explained by slight DNA deg-
radation of frozen samples during storage. It can also be 
the possible reason why the frozen samples produced a 
slightly smaller mean insert size than SCP samples. How-
ever, our data revealed that SCP had little effect on com-
mon sequencing quality metrics and average depth of 
coverage for individual genes. These findings suggest that 
SCP preservation posed no or negligible effects on NGS 
testing, and DNA derived from SCP treated samples is 
suitable for NGS analysis.
As with DNA, it is also well known that formalin can 
react with RNA causing damage, fragmentation and 
altered amplification profiles [22]. We did a similar study 
of small sample size to compare the effects of fixatives on 
RNA performance. Our preliminary data showed that 
SCP was compatible with RNA extraction and reverse 
transcription PCR amplification of HER-2 mRNA and 
GAPDH mRNA, whereas NBF fixation resulted in a very 
poor RNA yield and significantly low mRNA copy num-
bers (data not shown).
Utilization of molecular testing is growing. It is essen-
tial to develop formalin substitute fixatives for molecular 
assay development and clinical practice without sig-
nificantly compromising histomorphologic features. A 
number of molecular fixatives have been reported. For 
example, alcohol-based fixatives such as CyMol, UPM, 
and UMFIX can penetrate into and fix tissues quickly 
by denaturing, instead of cross-linking, proteins [9, 23]. 
However, tissues can become very hard and cells are 
prone to shrinkage during alcohol-based fixative process 
[24]. SCP contains no alcohol or formalin. To our knowl-
edge, this is the first study focusing on SCP molecular 
preservation features. Our research demonstrated that 
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SCP had little adverse effects on widely used molecular 
technologies. Although using a cancer cell line model is 
a good choice for a pilot investigation like this study, it 
would be very interesting to perform similar studies on 
tissues samples, especially surgical biospecimens. In the 
future, we hope to investigate various preanalytical fac-
tors of SCP fixation such as fixation time, specimen size, 
and type of tissue. Collecting more data on RNA and 
NGS testing will be beneficial too.
In conclusion, our study provides experimental evi-
dence that cells preserved with SCP can maintain the 
integrity of nucleic acids for downstream molecular anal-
ysis including PCR amplification, FISH, and NGS. SCP 
provides key advantages in nucleic acid detection and can 
be a potential substitute for formalin with further assess-
ment and improvement of current protocols.
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